Caris Life Sciences and ConcertAI Expand Partnership to Create First-in-Class, Prospectively Matched Clinico-Genomic Research Platform
Contemporaneously Combining Comprehensive Molecular Profiling at Unprecedented Scale with Reference-standard Clinical Data Creates a Novel Platform to Advance Precision Oncology Research IRVING, Texas and CAMBRIDGE, Mass., June 1, 2023 /PRNewswire/ — Caris Life Sciences®(Caris), the leading molecular science, artificial intelligence (AI) and machine learning technology company actively developing and delivering innovative solutions to revolutionize healthcare, … Read more